MedPath

Buspirone Hydrochloride

Approved
Approval ID

270398a0-21b8-407b-af76-4aeef90f72be

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 28, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

buspirone hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72789-332
Application NumberANDA075388
Product Classification
M
Marketing Category
C73584
G
Generic Name
buspirone hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJuly 28, 2023
FDA Product Classification

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
BUSPIRONE HYDROCHLORIDEActive
Quantity: 15 mg in 1 1
Code: 207LT9J9OC
Classification: ACTIB
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/6/2024

Principal Display Panel

BusPIRone
** Hydrochloride**
** Tablets, USP**

15 mg

PHARMACIST: DISPENSE WITH PATIENT
INFORMATION SHEET

Rx only

Print Patient Information Sheet at:
https://www.oxford-rx.com/med-guides

image

DESCRIPTION SECTION

LOINC: 34089-3Updated: 7/17/2020

DESCRIPTION

Buspirone hydrochloride tablets, USP is an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.

Buspirone hydrochloride is a white crystalline, water soluble compound with a molecular weight of 422.0. Chemically, buspirone hydrochloride is 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione monohydrochloride. The empirical formula C 21H 31N 50 2• HCl is represented by the following structural formula:

Structural Formula

Buspirone hydrochloride, USP is supplied as tablets for oral administration containing 5 mg, 10 mg, 15 mg, or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 9.1 mg, and 13.7 mg and 27.4 mg of buspirone free base, respectively). The 5-mg and 10-mg tablets are scored so they can be bisected. Thus, the 5-mg tablet can also provide a 2.5-mg dose, and the 10-mg tablet can provide a 5-mg dose. The 15-mg and 30-mg tablets are provided in the adjustable dosage tablet design. These tablets are scored so they can be either bisected or trisected. Thus, a single 15-mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two thirds of a tablet), 7.5 mg (one half of a tablet), or 5 mg (one third of a tablet). A single 30-mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two thirds of a tablet), 15 mg (one half of a tablet), or 10 mg (one third of a tablet). Buspirone hydrochloride, USP tablets contain the following inactive ingredients: colloidal silicon dioxide, lactose anhydrous, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate (Type A).

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 3/21/2022

HOW SUPPLIED:

Buspirone Hydrochloride Tablets, USP 15 mgare white rectangle, flat faced, beveled edge tablets double-scored and debossed with "0|9|3" on one side and double-scored and debossed "|O|" logo on the other side. Supplied in bottles of 60’s (NDC 72789-332-60).

Dispense 15 mg and 30 mg with Patient Information Sheet available at: https://www.oxford-rx.com/med-guides

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP controlled room temperature].

Dispense in a tight, light-resistant container (USP).

REFERENCES SECTION

LOINC: 34093-5Updated: 3/17/2022

REFERENCE

  1. American Psychiatric Association, Ed.: Diagnostic and Statistical Manual of Mental Disorders—III, American Psychiatric Association, May 1980.

Synthroid® is the registered trademark of Abbott Laboratories.

Manufactured by:
Oxford Pharmaceuticals LLC
301 Leaf Lake Parkway
Birmingham, AL 35211 USA

8200017
02/22
R03

Patient Information Sheet
****BUSPIRONE HYDROCHLORIDE, USP

Rx Only


Dispense with Patient Information Sheet available at:
**** https://www.oxford-rx.com/med-guides

HOW TO USE:
Buspirone Hydrochloride Tablets, USP
15 mg and 30 mg Tablets
in convenient adjustable dosage tablet form

Response to buspirone varies among individuals. Your physician may find it necessary to adjust your dosage to obtain the proper response.

This adjustable dosage tablet design makes dosage adjustments easy. Each tablet is scored and can be broken accurately to provide any of the following dosages.

If your doctor prescribed
the 30-mg tablet:

If your doctor prescribed
the 15-mg tablet:

30 mg (the entire tablet)
30 mg
(the entire tablet)

15 mg (the entire tablet)
15 mg
(the entire tablet)

20 mg (two thirds of a tablet)
20 mg
(two thirds of a tablet)

10 mg ( two thirds of a tablet)
10 mg
(two thirds of a tablet)

10 mg (one third of a tablet)
10 mg
(one third of a tablet)

5 mg (one third of a tablet)
5 mg
(one third of a tablet)

15 mg entire tablet
15 mg
(one half of a tablet)

7.5 xxx
7.5 mg
(one half of a tablet)

To break a adjustable dosage tablet accurately and easily, hold the tablet between your thumbs and index fingers close to the appropriate tablet score (groove) as shown in the photo. Then, with the tablet score facing you, apply pressure and snap the tablet segments apart (segments breaking incorrectly should not be used).

break in half

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Buspirone Hydrochloride - FDA Drug Approval Details